Regev and colleagues describe the role of BACH2 in promoting immunomodulatory Th17 cells. Read it here: rdcu.be/dP2m6 nature.com/articles/s4159…

Irvine and colleagues suggest that targeting IL-12 and IL-15 to CD45 is an effective antitumor treatment and limits adverse effects associated with cytokine therapies. Read it here: rdcu.be/dQQkz nature.com/articles/s4159…

Registered check! Max Cooper yo.

Circa 2018

💥 Amazing Grand Rounds Lecture ⁦Winship Cancer Institute of Emory University⁩ today by the exceptionally talented ⁦Allison Betof Warner, MD, PhD⁩ from ⁦Stanford Medicine⁩ on TIL & CAR T cell therapy! Such an inspiring and dynamic innovator. 💥

August Society for Immunotherapy of Cancer #JITC Reading List by Deputy Editor-in-Chief Sjoerd van der Burg LUMC Leiden selection #2: Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy by WashU Medicine Asher Biotherapeutics bit.ly/4dV6KZz

Spontaneous tumor regression following COVID-19 vaccination | Journal for ImmunoTherapy of Cancer jitc.bmj.com/content/10/3/e…

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis jitc.bmj.com/content/10/12/…

Targeting tumor-associated macrophage-derived CD74 improves efficacy of neoadjuvant chemotherapy in combination with PD-1 blockade for cervical cancer | Journal for ImmunoTherapy of Cancer jitc.bmj.com/content/12/8/e…

Augmenting CAR T-cell Functions with LIGHT | Cancer Immunology Research | American Association for Cancer Research aacrjournals.org/cancerimmunolr…

Hot off the press 6k paper! ♨️ Check out this #FridayRead in Nature Immunology. Stanford researchers profiled 2.5M+ cells in 130 tumors using 1k & 6k RNA panels, mapping high-grade ovarian cancer & revealing immune evasion mechanisms 👉nature.com/articles/s4159…

PTPN1/PTPN2 inhibitor with ICB or ACT maybe….Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer | Nature Immunology nature.com/articles/s4159…

Vincenzo Bronte: CLDN18 is a prognostic marker for survival in #pancreatic #cancer - increased CLDN18 expression is correlated with increased survival.

Please donate to our 2024 Winship 5K Run/Walk: PaulosLab: T cells kill cancer - Emory University secure2.convio.net/emory/site/TR/…

2 things I noticed with the highest achievers in the world: 1. They exercise 2. They walk a lot These are non-negotiables when you’ve got a high workload and big goals.

The ⁦Paulos Lab⁩ is excited to rotate Sònia Mecorapaj in the lab! 🥼